PLPP5 and hepatocellular carcinoma: In conclusion, our data support the hypothesis that HTPAP promoter polymorphisms contribute to the prognosis of HCC patients, and this may be due to the presence of SNPs in the HTPAP promoter that modify the transcriptional activity and expression level of HTPAP.